StockData
Sanofi logo

Sanofi

SNYNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SNYNF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 17, 2026Score 6/30
$47.12−0.41 (-0.86%)

Close on Nov 18, 2026Market cap $114.92BP/E 13.4Yield –

Sanofi Weighted-Average Basic Shares Outstanding by Quarter

Weighted-Average Basic Shares Outstanding (M)

Sanofi Weighted-Average Basic Shares Outstanding: 1,200M in Q3 2026, down 1.5% from a year earlier.

Latest, Q3 2026
1,200
Period ended Sep 30, 2026
Change on a year earlier
-1.5%
1,218 in Q3 2025
History
15 quarters
Since Q1 2023
Sources
9
Documents cited below

Where the Q3 2026 figure comes from

Source: Sanofi Q3 2026 Earnings Release Form 6-K (filed 2026-10-30) ↗

Reported in Sanofi Form 6-K Appendix 2/3 & Form 20-F.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedWeighted-Average Basic Shares Outstanding (M)Year on yearSource
Q3 2026Sep 30, 20261,200-1.5%Sanofi Q3 2026 Earnings Release Form 6-K (filed 2026-10-30) ↗
Q2 2026Jun 30, 20261,197-1.7%Sanofi Q2 2026 Earnings Release Form 6-K (filed 2026-07-30) ↗
Q1 2026Mar 31, 20261,204-2.4%Sanofi Q1 2026 Earnings Release Form 6-K (filed 2026-04-23) ↗
Q4 2025Dec 31, 20251,213-3.3%Sanofi Q4 2025 Earnings Release Form 6-K (filed 2026-01-29) ↗
Q3 2025Sep 30, 20251,218-2.8%Sanofi Q3 2026 Earnings Release Form 6-K (filed 2026-10-30) ↗
Q2 2025Jun 30, 20251,217-2.6%Sanofi Q2 2026 Earnings Release Form 6-K (filed 2026-07-30) ↗
Q1 2025Mar 31, 20251,234-1.2%Sanofi Q1 2026 Earnings Release Form 6-K (filed 2026-04-23) ↗
Q4 2024Dec 31, 20241,2540.0%Sanofi Q4 2025 Earnings Release Form 6-K (filed 2026-01-29) ↗
Q3 2024Sep 30, 20241,2530.0%Sanofi Q3 2025 Earnings Release Form 6-K (filed 2025-10-24) ↗
Q2 2024Jun 30, 20241,2500.0%Sanofi Q2 2025 Earnings Release Form 6-K (filed 2025-07-31) ↗
Q1 2024Mar 31, 20241,2490.0%Sanofi Q1 2025 Earnings Release Form 6-K (filed 2025-04-24) ↗
Q4 2023Dec 31, 20231,254–Sanofi Q4 2024 Earnings Release Form 6-K (filed 2025-01-30) ↗
Q3 2023Sep 30, 20231,253–Sanofi Historical Profit & Loss Excluding Opella Workbook (2023–2024 Restated) ↗
Q2 2023Jun 30, 20231,251–Sanofi Historical Profit & Loss Excluding Opella Workbook (2023–2024 Restated) ↗
Q1 2023Mar 31, 20231,249–Sanofi Historical Profit & Loss Excluding Opella Workbook (2023–2024 Restated) ↗

Cite this data

StockData. (2026). Sanofi Weighted-Average Basic Shares Outstanding (M), quarterly Q1 2023–Q3 2026 [Data set]. Compiled from Sanofi SEC filings and investor materials. https://stockdatahq.com/stocks/sny/kpis/ifrs-shares-basic

See every metric in the Sanofi KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?